
Rabegut-L 75mg/20mg Capsule SR
Manufacturer
NGS Biotech Pvt Ltd
Salt Composition
Levosulpiride (75mg) + Rabeprazole (20mg)
Key Information
Short Description
Rabegut-L 75mg/20mg Capsule SR is a prescription medicine used to treat gastroesophageal reflux disease (acid reflux), intestinal ulcers, and irritable bowel syndrome.
Dosage Form
Capsule SR
Introduction
Rabegut-L 75mg/20mg Capsule SR is taken with or without food in a dose and duration as advised by the doctor. The dose you are given will depend on your condition and how you respond to the medicine. You should keep taking this medicine for as long as your doctor recommends. If you stop treatment too early your symptoms may come back and your condition may worsen. Let your healthcare team know about all other medications you are taking as some may affect or be affected by this medicine.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Rabegut-L 75mg/20mg Capsule SR is to be taken empty stomach.
Safety Information
Side Effects
The most common side effects are nausea, stomach pain, diarrhea, flatulence, constipation, headache, weakness, and flu-like symptoms.
Alcohol Warning
It is unsafe to consume alcohol with Rabegut-L 75mg/20mg Capsule SR.
Breastfeeding Warning
Information regarding the use of Rabegut-L 75mg/20mg Capsule SR during breastfeeding is not available. Please consult your doctor.
Pregnancy Warning
Rabegut-L 75mg/20mg Capsule SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Rabegut-L 75mg/20mg Capsule SR is a combination of two medicines: Levosulpiride and Rabeprazole.
Quick Tips
Do not consume alcohol while taking Rabegut-L 75mg/20mg Capsule SR as it can increase the risk of stomach damage. Long-term use may cause weak or broken bones. Take adequate intake of dietary calcium and vitamin D or their supplements. Do not take Rabegut-L 75mg/20mg Capsule SR for longer than prescribed.
Related Medicines

Acera-L Capsule SR

Colosafe-L Capsule SR

Ansuper-Plus Capsule SR

Rablet L Capsules

Rabemac LS Capsule

Rabonik Plus Capsule SR

Razo-L Capsule

Veloz L Capsule

Rebirica L Capsule SR

Rabirant-LSR Capsule
Frequently asked questions
When should I take Rabegut-L 75mg/20mg Capsule SR?
Take Rabegut-L 75mg/20mg Capsule SR exactly as directed by your doctor. It is best to take one capsule daily on an empty stomach.
Are there any contraindications for the use of Rabegut-L 75mg/20mg Capsule SR?
Use of Rabegut-L 75mg/20mg Capsule SR should be avoided in patients with known allergy to any of the components or excipients of this medicine.
Can Rabegut-L 75mg/20mg Capsule SR cause dizziness?
Yes, some individuals may experience dizziness (feeling faint, weak, unsteady or lightheaded) after taking Rabegut-L 75mg/20mg Capsule SR. If you feel dizzy, it is recommended to rest until your symptoms subside.
Does the use of Rabegut-L 75mg/20mg Capsule SR increase the risk of fractures?
Some studies in adults have suggested that Rabegut-L 75mg/20mg Capsule SR treatment may be associated with an increased risk of osteoporosis-related fractures, particularly in the hip, wrist, or spine. This risk is elevated in patients who are administered high doses for long durations (one year or more).
Can I drive while taking Rabegut-L 75mg/20mg Capsule SR?
Rabegut-L 75mg/20mg Capsule SR may cause drowsiness, dizziness, or blurry vision. Therefore, it is advisable to avoid driving or operating machinery until you are fully aware of its effects on your body.
How should I store and dispose of Rabegut-L 75mg/20mg Capsule SR?
Store Rabegut-L 75mg/20mg Capsule SR in its original packaging, tightly sealed. Follow the storage instructions provided on the product label or package. Properly discard unused medication to prevent accidental consumption by children, pets, or other individuals.